Will GM Insects Help Stop Disease?

A variety of genetic strategies to counter insect-borne diseases are close to maturity.

Written bySabrina Richards
| 4 min read
mosquito gm insect

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Insects transmit some of the world’s most debilitating pathogens, including those responsible for malaria, dengue fever, Chagas disease, and sleeping sickness. So, naturally, the best way to fight these life-threatening diseases is at their source. Historically, malaria and dengue control strategies have incorporated insect population control using insecticides, but in recent years, researchers have turned to genetic engineering. By developing mosquitoes that don’t carry such pathogens, researchers hope to stop disease spread in its tracks.

After many years of hopeful development, such genetically modified mosquitoes might finally be close to proving their worth. Field tests of genetically-sterilized mosquitoes, targeted at dengue-carrying species, are demonstrating encouraging suppression of mosquito populations, while a variety of genetically manipulated malaria- or dengue-resistant mosquitoes are nearing their chance at tackling mosquito-borne infections outside the laboratory.

Researchers creating genetically modified (GM) insects generally have one of two goals. “I call them the ‘bite, no-bite’ strategies,” said ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies